Response rate shows potential of ficlatuzumab with chemotherapy in treating AML Aug. 9, 2021 No Comments
ImmVira receives NMPA approval for clinical testing of intravenous MVR-T3011 Aug. 9, 2021 No Comments
Exicure provides updated interim data from phase Ib/II study of cavrotolimod Aug. 6, 2021 No Comments
Nordic Nanovector resets expected timeline for phase IIb PARADIGME study of Betalutin Aug. 4, 2021 No Comments
RSS